Abstract
ES-62, a filarial nematode-derived anti-inflammatory immunomodulator, was administered to mice in an attempt to prevent pathology associated with Toxoplasma gondii infection. The nematode product was shown to elevate mitogen and T. gondii-specific IL-10 production but was unable to inhibit Th1 responses. Consequently ES-62 could not prevent Th1 generated immunopathology. © 2005 Blackwell Publishing Ltd.
Original language | English |
---|---|
Pages (from-to) | 147-150 |
Number of pages | 3 |
Journal | Parasite Immunology |
Volume | 27 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2005 |
Keywords
- ES-62
- Immunomodulation
- Toxoplasma gondii